|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-4-27
|
|
pubmed:abstractText |
To prepare for yttrium-90 ((90)Y) microsphere radioembolization therapy, digital subtraction angiography (DSA) and technetium- 99m-labeled macroaggregated albumin ((99m)Tc MAA) scintigraphy are used for treatment planning and detection of potential nontarget embolization. The present study was performed to determine if cone-beam computed tomography (CBCT) affects treatment planning as an adjunct to these conventional imaging modalities.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1535-7732
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
606-13
|
|
pubmed:meshHeading |
pubmed-meshheading:19345589-Adult,
pubmed-meshheading:19345589-Aged,
pubmed-meshheading:19345589-Cone-Beam Computed Tomography,
pubmed-meshheading:19345589-Embolization, Therapeutic,
pubmed-meshheading:19345589-Female,
pubmed-meshheading:19345589-Humans,
pubmed-meshheading:19345589-Liver Neoplasms,
pubmed-meshheading:19345589-Male,
pubmed-meshheading:19345589-Middle Aged,
pubmed-meshheading:19345589-Radiography, Interventional,
pubmed-meshheading:19345589-Radiopharmaceuticals,
pubmed-meshheading:19345589-Radiotherapy Dosage,
pubmed-meshheading:19345589-Radiotherapy Planning, Computer-Assisted,
pubmed-meshheading:19345589-Treatment Outcome,
pubmed-meshheading:19345589-Yttrium Radioisotopes
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization.
|
|
pubmed:affiliation |
Department of Radiology, Stanford University Medical Center, CA 94305-5642, USA. jdlouie@stanford.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
